pinkgrass1
About
Correction to: Serious hypoglycemia caused by a little serving associated with repaglinide along with concurrent use of nilotinib along with febuxostat in a individual using type 2 diabetes.
Correction to: Serious hypoglycemia caused by a little serving associated with repaglinide along with concurrent use of nilotinib along with febuxostat in a individual using type 2 diabetes.